MetaADEDB 2.0 @ LMMD
Cilastatin, Imipenem Drug Combination
(NCCJWSXETVVUHK-ZYSAIPPVSA-N)
Structure
SMILES
C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.OC(=O)[C@H](CSCCCC/C=C(/C(=O)O)\NC(=O)[C@H]1CC1(C)C)N
Molecular Formula:
C28H43N5O9S2
Molecular Weight:
657.799
Log P:
2.7763
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
7
TPSA:
296.54
CAS Number(s):
N/A
Synonym(s)
1.
Cilastatin, Imipenem Drug Combination
2.
Imipenem - Cilastatin
3.
Imipenem - Cilastatin Sodium
4.
Imipenem Cilastatin
5.
Imipenem Cilastatin Sodium
6.
Imipenem-Cilastatin
7.
Imipenem-Cilastatin Sodium
8.
Imipenem-Cilastatin, Sodium Salt
9.
MK 0787-MK 0791 mixture
10.
MK 787-MK 791 mixture
11.
Primaxin
12.
Thienam
13.
Tienam 500
14.
Zienam
15.
Cilastatin, Imipenem
16.
Imipenem Cilastatin, Sodium Salt
17.
MK 0787 MK 0791 mixture
18.
MK 787 MK 791 mixture
External Link(s)
MeSHD000077728
PubChem Compound17756656
CHEMBLCHEMBL1628401
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 7US FAERS
2EpilepsyFAERS: 615143958CTD
US FAERS
3DeliriumFAERS: 4US FAERS
4Pathogen resistanceFAERS: 3US FAERS
5Drug resistanceFAERS: 2US FAERS
6Incorrect route of drug administrationFAERS: 2US FAERS
7NauseaFAERS: 29681765CTD
US FAERS
8PruritusFAERS: 210052540CTD
US FAERS
9nervous system disorderFAERS: 2US FAERS
10Acute kidney injuryFAERS: 1US FAERS
11AgitationFAERS: 1US FAERS
12Anaphylactoid ReactionFAERS: 1US FAERS
13Antibiotic level above therapeuticFAERS: 1US FAERS
14Biliary tract infectionFAERS: 1US FAERS
15Blood creatinine increasedFAERS: 1US FAERS
16Blood glucose increasedFAERS: 1US FAERS
17Blood urea increasedFAERS: 1US FAERS
18BronchitisFAERS: 1US FAERS
19ChillsFAERS: 1US FAERS
20Clostridium difficile infectionFAERS: 1US FAERS
21Device deposit issueFAERS: 1US FAERS
22DisorientationFAERS: 1US FAERS
23DysarthriaFAERS: 1US FAERS
24DysuriaFAERS: 1US FAERS
25EndocarditisFAERS: 1US FAERS
26Foaming at mouthFAERS: 1US FAERS
27Gastrointestinal infectionFAERS: 1US FAERS
28HypersensitivityFAERS: 1US FAERS
29Medication ErrorFAERS: 1US FAERS
30OliguriaFAERS: 1US FAERS
31Otitis MediaFAERS: 1US FAERS
32OverdoseFAERS: 1US FAERS
33PancreatitisFAERS: 1US FAERS
34PneumoniaFAERS: 1US FAERS
35Product label issueFAERS: 1US FAERS
36Product preparation errorFAERS: 1US FAERS
37Product quality issueFAERS: 1US FAERS
38Psychiatric symptomFAERS: 1US FAERS
39Pyoderma GangrenosumFAERS: 1US FAERS
40RestlessnessFAERS: 1US FAERS
41RetchingFAERS: 1US FAERS
42Septic ShockFAERS: 1US FAERS
43ShockFAERS: 1US FAERS
44SomnolenceFAERS: 1US FAERS
45Status EpilepticusFAERS: 1US FAERS
46Therapy non-responderFAERS: 1US FAERS
47ThrombocytopeniaFAERS: 1US FAERS
48TrismusFAERS: 1US FAERS
49Unevaluable eventFAERS: 1US FAERS
50Venous InjuryFAERS: 1US FAERS
51Wrong doseFAERS: 1US FAERS
52Wrong technique in product usage processFAERS: 1US FAERS
53prostatitisFAERS: 1US FAERS
54Azotemia29775647CTD
55Bacterial Infections29775647CTD
56Basal Ganglia Diseases9681765CTD
57Cholangitis11422785CTD
58Cholestasis11422785CTD
59Exanthema9158321
9681765
10052540
CTD
60Fever11033734CTD
61Gram-Negative Bacterial Infections8158196
9681765
CTD
62Gram-Positive Bacterial Infections8158196
9681765
CTD
63Kidney Diseases10217324CTD
64Meningitis, Bacterial2062603
7625802
CTD
65Meningitis, Pneumococcal8515296CTD
66Myasthenia Gravis8158196CTD
67Myoclonus10052540CTD
68Peritonitis9681765
10052540
CTD
69Polyuria29775647CTD
70Postoperative Complications9158321CTD
71Seizures

View details

CTD
72Staphylococcal Infections8150772CTD
73Testicular Diseases30721722CTD
74Tremor9681765CTD
75Urinary Calculi29775647CTD
76Vasculitis, Leukocytoclastic, Cutaneous9158321CTD
77Vertigo1949961CTD
78Vomiting9681765CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.